All for Joomla All for Webmasters

EULAR recommendations for the use and interpretation of laboratory diagnostic tests for the management of systemic autoimmune rheumatic diseases

Rate this item
(9 votes)
 

Questions/answers on EULAR recommendations for the use and interpretation of laboratory diagnostic tests for the management of systemic autoimmune rheumatic diseases

In the case of isolated medium/high titer positivity, the decision how/whether to perform further investigation or to treat a patient suffering from a possible SARD eventually depends on the whole clinical picture (clinical manifestations, family history, age, sex & lab results). For example, an isolated ANA positivity at medium/high titer in a young lady with photosensitivity, sicca syndrome or Raynaud phenomenon suggests an underlying SARD and deserves further investigations (e.g. ophthalmological evaluation, capillaroscopy etc). On the contrary, the same isolated positivity associated with arthralgias (non arthritis) only is much less predictive for a SARD (Mahler M et al. J Immunol Res. 2014;2014:263091).

Yes. We can do it even now although in particular contexts only. Regarding the example reported at the point n.1: a young lady positive for ANA at medium/high titer with a centromeric staining pattern should be evaluated for the capillaroscopy and in case of a scleroderma pattern we can predict a specific subset of scleroderma (i.e. limited scleroderma - lSSc). The prognosis and management of lSSc is different from the systemic variant (Bossuyt X et al. Nat Rev Rheumatol. 2020 Nov 5. doi: 10.1038/s41584-020-00522-w. Epub ahead of print. PMID: 33154583).

If you mean a single ANA positivity in a solid phase assay (e.g. CTD screening test), such a positivity is more specific/predictive from a diagnostic point of view than IFA-HEp2. A positive result should suggest a further work out or follow up to the clinician. The opposite (isolated ANA IFA-HEp2 positivity and negative solid phase assay) is much less specific/predictive for a SARD (Bossuyt X et al. Nat Rev Rheumatol. 2020 Nov 5. doi: 10.1038/s41584-020-00522-w. Epub ahead of print. PMID: 33154583).

Additional Info

Read 2769 times

Werfen.com. All rights Reserved. Privacy Policy | Cookies Policy | Terms of Service

No Internet Connection